Assessment of Disease Activity in Behcet by Complete Blood Count
Serum (PLR), (LMR), (MPV) and (NLR) in Behcet Disease and Their Correlation With Disease Activity
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
- To determine platelet to lymphocyte ratio (PLR), lymphocytes to monocytes ratio (LMR), mean platelet volume (MPV) and neutrophile lymphocyte ratio (NLR), levels in Behçet's disease (BD)
- To investigate their correlation with disease activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2018
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 11, 2018
CompletedFirst Posted
Study publicly available on registry
November 20, 2018
CompletedStudy Start
First participant enrolled
December 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2019
CompletedNovember 20, 2018
November 1, 2018
9 months
November 11, 2018
November 17, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
serum (PLR), (LMR), (MPV) and (NLR) in behcet disease and their correlation with disease activity.
* To determine platelet to lymphocyte ratio (PLR), lymphocytes to monocytes ratio (LMR), mean platelet volume (MPV) and neutrophile lymphocyte ratio (NLR), levels in Behçet's disease (BD) * To investigate their correlation with disease activity
baseline
Study Arms (2)
complete blood count
ACTIVE COMPARATORblood samples will be taken from patient and complete blood count is done early morning
erythrocyte sedimentation rate
ACTIVE COMPARATORblood samples will be taken from patient and erythrocyte sedimentation rate is done
Interventions
Eligibility Criteria
You may qualify if:
- Patient diagnosed as behcet disease by a rheumatologist
- Age from 18 to 70 years old
You may not qualify if:
- \- Skin diseases,
- Autoimmune diseases,
- Inflammatory or infectious diseases,
- Allergy,
- Subjects with chronic diseases such as cardiovascular disorders, diabetes mellitus, or hematological, kidney, or liver diseases, hypertension, or malignant diseases
- unwilling to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Jiang Y, Zang M, Li S. Serum PLR and LMR in Behcet's disease: Can they show the disease activity? Medicine (Baltimore). 2017 May;96(21):e6981. doi: 10.1097/MD.0000000000006981.
PMID: 28538403BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
esraa omar, master
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principle investigator
Study Record Dates
First Submitted
November 11, 2018
First Posted
November 20, 2018
Study Start
December 1, 2018
Primary Completion
September 1, 2019
Study Completion
October 1, 2019
Last Updated
November 20, 2018
Record last verified: 2018-11
Data Sharing
- IPD Sharing
- Will not share